Navigation Links
Ex-Allergan Vice President Joins Kalologie Skincare Board of Directors
Date:3/19/2008

SANTA MONICA, Calif., March 19 /PRNewswire/ -- Kalologie Skincare today announced that Niv Edward Caviar, Executive Vice President of La Jolla Pharmaceutical Company, was elected to Kalologie Skincare's board of directors. Mr. Caviar previously served as Vice President of Allergan Inc.

"Niv is a strong marketer with solid operational skills," said William Brennan, Kalologie's CEO. "We look forward to benefiting from Niv's unique insight in the growing aesthetic skin care industry."

"Over the past five years, Kalologie has positioned itself to become a leading provider of aesthetic skin care products and services," said Niv Edward Caviar. "I look forward to working with the Company to help facilitate future growth, especially through the company's physician-only franchise program."

At Allergan, Mr. Caviar was Vice-President of Business Development and then Vice-President and Head of Marketing for Medical Dermatology. In his latter role, Mr. Caviar led all operational and strategic marketing activities for Allergan's U.S medical dermatology franchise. Brands under his responsibility included Tazorac(R), Avage(R), and Botox(R) for Medical Dermatology uses. Mr. Caviar is presently Executive Vice-President and Chief Business and Financial Officer of La Jolla Pharmaceutical Co., a San Diego-based biotech company focused on developing innovative pharmaceutical products. La Jolla Pharmaceutical's leading product in development is Riquent(R) (abetimus sodium), which is currently being studied to help treat and maintain remission in patients with lupus renal disease.

Mr. Caviar received an M.B.A. from Harvard University and a B.S. in Mechanical Engineering from the U.S. Air Force Academy. Prior to his work at Allergan, Mr. Caviar served as a captain in the U.S. Air Force where he worked as a Solid Rocket Motor Engineer and was a Project Manager for the U.S. Space Command on both the Titan IV Rocket and the Space Shuttle Solid Rocket Motor Programs.

Founded in 2003, Kalologie is a chain of comprehensive, one-stop skin care clinics offering effective medical and aesthetic skin care treatments such as Botox(R), Juvederm, Restylane, IPL Photo Facials, Laser Hair Removal, Facials and Chemical Peels. In addition the Company offers a proprietary line of Kalologie-branded skin care products.

Kalologie Franchising, LLC, with headquarters in Santa Monica, California, is a solution-oriented skin care company offering a comprehensive approach to address the unique challenges of each individual's skin. http://www.kalologie.com

For press inquiries, please contact Sarah Lopez; sarah_lopez@kalologie.com; (310) 961-2077.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Kalologie Franchising, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Three CEOs and University President Named Winners of Greater Baltimore Committees 2008 Baltimore Region Bioscience Awards
2. Dr. Linda McAllister Joins Arbor Vita Corporation as Vice President of Diagnostics
3. iCAD Appoints John DeLucia as Vice President of Quality Assurance and Regulatory Affairs
4. Cato Research Names John Cline as President
5. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
6. febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales
7. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
8. Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
9. MiMedx Announces Brian J. Splan as President
10. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
11. Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... ... Information Management Services ( IMS ) is pleased to announce a major upgrade ... and is so significant it was endowed with a new name, BSI Engage. ... a streamlined layout and a more intuitive format for navigating the system. ...
(Date:2/8/2016)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that its new website has gone live. On Thursday, ... mobile-friendly. Visit the new site: www.diplomat.is ... ... ... "The goal was to reimagine the website and create ...
(Date:2/5/2016)...  In the pharmaceutical industry the medical affairs function ... activities including the identification and engagement of key thought ... high in the oncology therapeutic area where most treating ... Role of Medical Affairs in Oncology Launch Excellence ." ... find better ways to utilize medical affairs to develop ...
(Date:2/4/2016)... 4, 2016 - New FDA action date of ... New FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast ... decade indicated for the treatment of signs and symptoms of dry ... the potential to be the only product approved in the U.S. in the past decade ...
Breaking Biology Technology:
(Date:2/3/2016)... PUNE, India , February 3, 2016 ... to the new market research report "Automated Fingerprint Identification ... (Tenprint Search, Latent Search), Application (Banking & Finance, Government, ... 2020", published by MarketsandMarkets, the market is expected to ... estimated CAGR of 21.0% between 2015 and 2020. The ...
(Date:2/3/2016)... 3, 2016 ... the "Emotion Detection and Recognition Market ... Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020" ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition ...
(Date:2/2/2016)... This BCC Research report provides a ... the recent advances in high throughput ‘omic platforms ... forward. Includes forecast through 2019. Use ... opportunities that exist in the bioinformatic market. Analyze ... well as IT and bioinformatics service providers. Analyze ...
Breaking Biology News(10 mins):